SEARCH

SEARCH BY CITATION

References

  • Akkus E., Kadioglu A., Esen A., Doran S., Ergen A., Anafarta K., Hattat H., Turkish Erectile Dysfunction Prevalence Study Group. Prevalence and correlates of erectile dysfunction in Turkey: a population-based study. Eur Urol. 2002;41: 298304.
  • Allan CA, Forbes EA, Strauss BJ, McLachlan RI. Testosterone therapy increases sexual desire in ageing men with low-normal testosterone levels and symptoms of androgen deficiency. Int J Impot Res. 2008a;20: 396401.
  • Allan CA, Strauss BJ, Burger HG, Forbes EA, McLachlan RI. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. J Clin Endocrinol Metab. 2008b;93: 139146.
  • Andersson B., Marin P., Lissner L., Vermeulen A., Bjorntorp P.. Testosterone concentrations in women and men with NIDDM. Diabetes Care. 1994;17: 405411.
  • Ballester J., Muñoz MC, Domínguez J., Rigau T., Guinovart JJ, Rodríguez-Gil JE. Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. J Androl. 2004;25: 706719.
  • Basaria S., Muller DC, Carducci MA, Egan J., Dobs AS. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer. 2006;106: 581588.
  • Benitez A., Diaz J Perez. Effect of streptozotocin-diabetes and insulin treatment on regulation of Leydig cell function in the rat. Horm Metab Res. 1985;17: 57.
  • Blouin K., Despres JP, Couillard C., Tremblay A., Prud'homme D., Bouchard C., Tchernof A.. Contribution of age and declining androgen levels to features of the metabolic syndrome in men. Metabolism. 2005;54: 10341040.
  • Bodie J., Lewis J., Schow D., Monga M.. Laboratory evaluations of erectile dysfunction; an evidence based approach. J Urol. 2003;169: 22622264.
  • Boyanov MA, Boneva Z., Christov VG. Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male. 2003;6: 17.
  • Braun M., Wassmer G., Klotz T., Reifenrath B., Mathers M., Engelmann U.. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12: 305311.
  • Caprio M., Isidori AM, Carta AR, Moretti C., Dufau ML, Fabbri A.. Expression of functional leptin receptors in rodent Leydig cells. Endocrinology. 1999;140: 49394947.
  • Cersosimo E., DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22: 423436.
  • Chen RYT, Wittest GA, Andreson GR. Relative androgen deficiency in relation to obesity and metabolic status in older men. Diabetes Obes Metab. 2006;8: 429435.
  • Corona G., Mannucci E., Mansani R., Petrone L., Bartolini M., Giommi R., Forti G., Maggi M.. Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus. Eur Urol. 2004;46: 222228.
  • Corona G., Mannucci E., Petrone L., Balercia G., Paggi F., Fisher AD, Lotti F., Chiarini V., Fedele D., Forti G., Maggi M.. NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalnce of hypogonadism in male patients with sexual dysfunction. J Sex Med. 2007;4: 10381045.
  • Corona G., Mannucci E., Petrone L., Ricca V., Balercia G., Mansani R., Chiarini V., Giommi R., Forti G., Maggi M.. Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006;18: 190197.
  • Derweesh IH, DiBlasio CJ, Kincade MC, Malcolm JB, Lamar KD, Patterson AL, Kitabchit AE, Wake RN. Risk of new-onset diabetes mellitus and worsening glycemic variables for established diabetes in men undergoing androgen-deprivation therapy for prostate cancer. BJU Int. 2007;100: 10601065.
  • Dhindsa S., Prabhakar S., Sethi M., Bandyopadhyay A., Chaudhuri A., Dandona P.. Frequent occurrence of hypogonadotropic hypogonadism in type 2diabetes. J Clin Endocrinol Metab. 2004;89: 54625468.
  • Ding EL, Song Y., Malik VS, Liu S.. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295: 12881299.
  • Dockery F., Bulpitt CJ, Agarwal S., Donaldson M., Rajkumar C.. Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia. Clin Sci. 2003;104: 195201.
  • Esposito K., Ciotola M., Giuliano F., Schisano B., Improta L., Improta MR, Beneduce F., Rispoli M., DeSio M., Giuliano D.. Endothelial microparticles correlate with erectile dysfunction in diabetic men. Int J Impot Res. 2007;19: 161166.
  • Fonseca V., Seftel A., Denne J., Fredlund P.. Impact of diabetes mellitus on the severity of erectile dysfunction and response to treatment: analysis of data from tadalafil clinical trials. Diabetologia. 2004;47: 19141923.
  • Ford ES, Li C., Zhao G., Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among US adolescents using the definition from the international diabetes federation. Diabetes Care. 2008;31: 587589.
  • Fukui M., Soh J., Tanaka M., Kitagawa Y., Hasegawa G., Yoshikawa T., Miki T., Nakamura N.. Low serum testosterone concentration in middle-aged men with type 2 diabetes. Endocr J. 2007;54: 871877.
  • Fukui M., Tanaka M., Hasegawa G., Yoshikawa T., Nakamura N.. Association between serum bioavailable testosterone concentration and the ratio of glycated albumin to glycated hemoglobin in men with type 2 diabetes. Diabetes Care. 2008;31: 397401.
  • Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest. 2000;106: 453458.
  • Giuliano FA, Leriche A., Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology. 2004;64: 11961201.
  • Grossman M., Thomas MC, Panagiotopoulos S., Sharpe K., Macisaac RJ, Clark S., Zajac JD, Jerums G.. Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93(5): 18341840.
  • Guay AT, Velasquez E., Perez JB. Characterization of patients in a medical endocrine-based center for male sexual dysfunction. Endocr Pract. 1999;5: 314321.
  • Gustafson B., Hammarstedt A., Andersson CX, Smith U.. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27: 22762283.
  • Haffner SM, Miettinen H., Karhapä P., Mykkänen L., Laakso M.. Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab. 1997;82: 18071809.
  • Haffner SM, Shaten J., Stern MP, Smith GD, Kuller L.. Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. Am J Epidemiol. 1996;143: 889897.
  • Haidar A., Yassin A., Saad F., Shabsigh R.. Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male. 2007;10: 189196.
  • Hong CY, Park JH, Ahn RS, Im SY, Choi HS, Soh J., Mellon SH, Lee K.. Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor alpha. Mol Cell Biol. 2004;24: 25932604.
  • Hutson JC, Stocco DM, Campbell GT, Wagoner J.. Sertoli cell function in diabetic, insulin-treated diabetic, and semi-starved rats. Diabetes. 1983;32: 112116.
  • Isidori AM, Caprio M., Strollo F., Moretti C., Frajese G., Isidori A., Fabbri A.. Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. J Clin Endocrinol Metab. 1999;84: 36733680.
  • Isidori AM, Strollo F., More M., Caprio M., Aversa A., Moretti C., Frajese G., Riondino G., Fabbri A.. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab. 2000;85: 19541962.
  • Jang Y., Kim OY, Ryu HJ, Kim JY, Song SH, Ordovas JM, Lee JH. Visceral fat accumulation determines postprandial lipemic response, lipid peroxidation, DNA damage, and endothelial dysfunction in nonobese Korean men. J Lipid Res. 2003;44: 23562364.
  • Kalinchenko SY, Kozlov GI, Gontcharov NP, Katsiya GV. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male. 2003;6: 9499.
  • Kapoor D., Aldred H., Clark S., Channer K., Jones T.. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes. Diabetes Care. 2007;30: 911917.
  • Kapoor D., Goodwin E., Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154: 899906.
  • Kovanecz I., Ferrini MG, Vernet D., Nolazco G., Rajfer J., Gonzalez-Cavadid NF. Pioglitazone prevents corporal veno-occlusive dysfunction in a rat model of type 2 diabetes mellitus. BJU Int. 2006;98: 116124.
  • Laaksonen DE, Niskanen L., Punnonen K., Nyyssonen K., Tuomainen TP, Salonen R., Rauramaa R., Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol. 2003;149: 601608.
  • Lage MJ, Barber BL, Markus RA. Association between androgen-deprivation therapy and incidence of diabetes among males with prostate cancer. Urology. 2007;70: 11041108.
  • Lindmark S., Burein J., Ericksson JW. Insulin resistance, endocrine function and adipokines in type 2 diabetes patients at different glycemic levels: potential impact for glucotoxicity in vivo. Clin Endocrinol. 2006;65: 301309.
  • Luukkaa V., Pesonen U., Huhtaniemi I., Lehtonen A., Tilvis R., Tuomilehto J., Houlu M., Huupponen R.. Inverse correlation between serum testosterone and leptin in men. J Clin Endocrinol Metab. 1998;83: 32433246.
  • Maggio M., Basaria S., Ceda GP, Ble A., Ling SM, Bandinelli S., Valenti G., Ferrucci L.. The relationship between testosterone and molecular markers of inflammation in older men. J Endocrinol Invest. 2005;28(11 suppl proceedings): 116119.
  • Maggio M., Blackford A., Taub D., Carducci M., Ble A., Metter EJ, Braga-Basaria M., Dobs A., Basaria S.. Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy. J Androl. 2006;27: 725728.
  • Malkin CJ, Pugh PJ, Jones RD, Kapoor D., Channer KS, Jones TH. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab. 2004;89: 33133318.
  • Marin P.. Testosterone and regional fat distribution. Obes Res. 1995;3(suppl 4): S609S612.
  • Marin P., Holmang S., Gustafsson C., Jonsson L., Kvist H., Elander A., Eldh J., Sjostrom L., Holm G., Bjorntorp P.. Androgen treatment of abdominally obese men. Obes Res. 1993;1: 245251.
  • Marin P., Holmang S., Jonsson L., Sjostrom L., Kvist H., Holm G., Lindstedt G., Bjorntorp P.. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes Relat Metab Disord. 1992;16: 991997.
  • Marin P., Lonn L., Andersson B., Oden B., Olbe L., Bengtsson BA, Bjorntorp P.. Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone. J Clin Endocrinol Metab. 1996;81: 10181022.
  • Morimoto S., Mendoza-Rodríguez CA, Hiriart M., Larrieta ME, Vital P., Cerbón MA. Protective effect of testosterone on early apoptotic damage induced by streptozotocin in rat pancreas. J Endocrinol. 2005;187: 217224.
  • Muller M., Grobbee DE, den Tonkelaar I., Lamberts SW, van Der Schouw YT. Endogenous sex hormones and metabolic syndrome in aging men. J Clin Endocrinol Metab. 2005;90: 26182623.
  • Mulligan T., Frick MF, Zuraw QC, Stemhagen A., McWhirter C.. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60: 762769.
  • Naharci MI, Pinar M., Bolu E., Olgun A.. Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism. Endocr Pract. 2007;13: 629635.
  • Nielsen TL, Hagen C., Wraae K., Brixen K., Petersen PH, Haug E., Larsen R., Andersen M.. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. J Clin Endocrinol Metab. 2007;92: 26962705.
  • Nishiyama T., Ishizaki F., Anraku T., Shimura H., Takahashi K.. The influence of androgen deprivation therapy on metabolism in patients with prostate cancer. J Clin Endocrinol Metab. 2005;90: 657660.
  • Norata GD, Tibolla G., Seccomandi PM, Poletti A., Catapano AL. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab. 2006;91: 546554.
  • Oh JY, Barrett-Connor E., Wedick NM, Wingard DL, Bernardo Rancho Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women; the Rancho Bernardo study. Diabetes Care. 2002;25: 5560.
  • Oltmanns KM, Fruehwald-Schultes B., Kern W., Born J., Fehm HL, Peters A.. Hypoglycemia, but not insulin, acutely decreases LH and T secretion in men. J Clin Endocrinol Metab. 2001;86: 49134919.
  • Osuna JA, Gomez-Perez R., Arata-Bellabarba G., Villaroel V.. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl. 2006;52: 355361.
  • Pagotto U., Gambineri A., Pelusi C., Genghini S., Cacciari M., Otto B., Castaneda T., Tschop M., Pasquali R.. Testosterone replacement therapy restores normal ghrelin in hypogonadal men. J Clin Endocrinol Metab. 2003;88: 41394143.
  • Parazzini F., Fabris F Menchini, Bortolotti A., Calabro A., Chatenoud L., Colli E., Landoni M., Lavezzari M., Turchi P., Sessa A., Mirone V.. Frequency and determinants of erectile dysfunction in Italy. Eur Urol. 2000;37: 4349.
  • Parikh NI, Pencine MJ, Wang TJ, Lanier KJ, Fox CS, D'Agostino RB, Ramachandran SV. Increasing trends in incidence of overweight and obesity over 5 decades. Amer J Med. 2007;120: 242250.
  • Park K., Ku JH, Kim SW, Paick JS. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int. 2005;95: 366370.
  • Pasquali R., Casimirri F., Cantobelli S., Melchionda N., Labate Morselli AM, Fabbri R., Capelli M., Bortoluzzi L.. Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism. 1991;40: 101104.
  • Pasquali R., Casimirri F., de Iasio R., Mesini P., Boschi S., Chierici R., Flamia R., Biscotti M., Vicennata V.. Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab. 1995;80: 654658.
  • Pasquali R., Macor C., Vicennati V., Novo F., de Lasio R., Mesini P., Boschi S., Casimirri F., Vettor R.. Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. Metabolism. 1997;46: 526529.0.
  • Pitteloud N., Dwyer AA, DeCruz S., Lee H., Boepple PA, Crowley WF Jr, Hayes FJ. Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men. J Clin Endocrinol Metab. 2008;93: 784791.
  • Pitteloud N., Hardin M., Dwyer AA, Valassi E., Yialamas M., Elahi D., Hayes FJ. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab. 2005a;90: 26362641.
  • Pitteloud N., Mootha VK, Dwyer AA, Hardin M., Lee H., Eriksson KF, Tripathy D., Yialamas M., Groop L., Elahi D., Hayes FJ. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005b;28: 16361642.
  • Ponholzer A., Temml C., Mock K., Marszalek M., Obermayr R., Madersbacher S.. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47: 8086.
  • Rader DJ. Effect of insulin resistance, dyslipidemia, and the intraabdominal adiposity on the development of cardiovascular disease and diabetes mellitus. Amer J Med. 2007;120: 512518.
  • Rhoden EL, Ribeiro EP, Riedner CE, Teloken C., Souto CA. Glycosylated haemoglobin levels and the severity of erectile function in diabetic men. BJU Int. 2005b;95: 615617.
  • Rhoden EL, Ribeiro EP, Teloken C., Souto CA. Diabetes mellitus is associated with subnormal serum levels of free testosterone in men. BJU Int. 2005b;96: 867870.
  • Romeo JH, Seftel AD, Madhun ZT, Aron DC. Sexual function in men with diabetes type 2: association with glycemic control. J Urol. 2000;163: 788791.
  • Saez JM. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev. 1994;15: 574626.
  • Schroeder ET, Zheng L., Ong MD, Martinez C., Flores C., Stewart Y., Azen C., Sattler FR. Effects of androgen therapy on adipose tissue and metabolism in older men. J Clin Endocrinol Metab. 2004;89: 48634872.
  • Selvin E., Feinleib M., Zhang L., Rohrmann S., Rifai N., Nelson W., Dobs A., Basaria S., Golden S., Platz E.. Androgens and diabetes in men. Diabetes Care. 2007;30: 234238.
  • Shabsigh R., Perelman MA, Lockhart DC, Lue TF, Broderick GA. Health issues of men: prevalence and correlates of erectile dysfunction. J Urol. 2005;174: 662667.
  • Shahani S., Braga-Basaria M., Basaria S.. Androgen deprivation therapy in prostate cancer & metabolic risk for atherosclerosis. J Clin Endocrinol Metab. In press.
  • Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166: 16601665.
  • Simon D., Charles MA, Nahoul K., Orssaud G., Kremski J., Hully V., Joubert E., Papoz L., Eschwege E.. Assocation between plasma total testosterone and cardiovascular risk factors in healthy adult men: the Telecom Study. J Clin Endocrinol Metab. 1997;82: 682685.
  • Smith JC, Bennett S., Evans LM, Kynaston HG, Parmar M., Mason MD, Cockcroft J.R., Scanlon MF, Davies JS. The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab. 2001;86: 42614267.
  • Steinbrook R.. Facing the diabetes epidemic—mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med. 2006;354: 545548.
  • Stellato RK, Feldman HA, Hamdy O., Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23: 490494.
  • Sun P., Cameron A., Seftel A., Shabsigh R., Niederberger C., Guay A.. Erectile dysfunction—an observable marker of diabetes mellitus? A large national epidemiological study. J Urol. 2006;176: 10811085.
  • Traish AM, Guay AT, Feeley R., Saad F.. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl. 2009;30(1): 1022.
  • Wabitsch M., Blum WF, Muche R., Braun M., Hube F., Rascher W., Heinze E., Teller W., Hauner H.. Contribution of androgens to the gender difference in leptin production in obese children and adolescents. J Clin Invest. 1997;100: 808813.
  • Weyer C., Funahashi T., Tanaka S., Hotla K., Matsuzawa Y., Pratley RE, Tataranni A.. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86: 19301935.
  • Yamasaki H., Ogawa K., Sasaki H., Nakao T., Wakasaki H., Matsumoto E., Furuta H., Nishi M., Ueda K., Iwo K., Nanjo K.. Prevalence and risk factors of erectile dysfunction in Japanese men with type 2 diabetes. Diabetes Res Clin Pract. 2004;66S: S173S177.
  • Yannucci J., Manola J., Garnick MB, Bhat G., Bubley GJ. The effect of androgen deprivation therapy on fasting serum lipid and glucose parameters. J Urol. 2006;176: 520525.
  • Yialamas MA, Dwyer AA, Hanley E., Lee H., Pitteloud N., Hayes FJ. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007;92: 42544259.
  • Zhang XH, Filippi S., Morelli A., Vignozzi L., Luconi M., Donati S., Forti G., Maggi M.. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. J Sex Med. 2006;3: 253266.
  • Zirkin BR, Chen H.. Regulation of Leydig cell steroidogenic function during aging. Biol Reprod. 2000;63: 977981.